ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $606,676 | -12.0% | 22,671 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $689,312 | -13.5% | 22,671 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $797,242 | -4.2% | 22,002 | +4.3% | 0.00% | 0.0% |
| Q4 2022 | $831,790 | -6.4% | 21,090 | -3.9% | 0.00% | 0.0% |
| Q3 2022 | $889,000 | +2.8% | 21,950 | +5.5% | 0.00% | 0.0% |
| Q2 2022 | $865,000 | -93.2% | 20,809 | -93.6% | 0.00% | -93.8% |
| Q1 2022 | $12,740,000 | -0.5% | 326,754 | +2.9% | 0.02% | +6.7% |
| Q4 2021 | $12,803,000 | +144.1% | 317,543 | +123.8% | 0.02% | +114.3% |
| Q3 2021 | $5,246,000 | +2032.5% | 141,895 | +2265.7% | 0.01% | – |
| Q2 2021 | $246,000 | -7.5% | 5,998 | 0.0% | 0.00% | – |
| Q1 2021 | $266,000 | -11.3% | 5,998 | 0.0% | 0.00% | – |
| Q4 2020 | $300,000 | – | 5,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |